Editing a plant's genes is only half the battle. Before a new, improved trait can ever reach a farmer's field, scientists ...
The company had fallen out of investor favor; its recovery was impressive.
Researchers testing out CRISPR systems found that their ability to disrupt gene expression was artificially enhanced by an ...
CRISPR's expanding pipeline could unlock significantly more value by 2031.
YouTube on MSN
Sickle cell wrecked her heart and sent her to the ER for years - CRISPR dropped her pain crises to zero
A lifetime of sudden, crushing pain had already damaged Victoria Gray’s heart and repeatedly sent her to the emergency r ...
Data presented in a late-breaking presentation at the European Society of Cardiology (ESC) Congress 2026--Phase 1a clinical ...
CRISPR Therapeutics stock has climbed in the shorter term but still carries a heavy five year loss, and current valuation ...
ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that ...
The ability to precisely adjust the expression of genes inside the human body—ramping up protective ones and tamping down ...
A Cleveland Clinic first-in-human clinical trial has shown that a one-time infusion of a gene-editing therapy using ...
CRISPR Therapeutics' current $5.6B market cap and $1.78B net cash position offer acquisition appeal. Click to know why CRSP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results